Risk factors for early mortality and morbidity after pneumonectomy
Küçük Resim Yok
Tarih
2014
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Baycinar Medical Publ-Baycinar Tibbi Yayincilik
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Background: This study aims to investigate possible risk factors which affect the mortality and morbidity of pneumonectomy patients due to the non-small cell lung cancer (NSCLC). Methods: Demographic, clinical and pathological features of 100 patients (96 males, 4 females; mean age 58.4 +/- 8.9 years; range 38 to 82 years) who underwent pneumonectomy between April 2008 and October 2009 were retrospectively analyzed. Results: The morbidity and mortality rates were found to be 56% and 14%, respectively. The complications included cardiopulmonary in 46%, bleeding in 7%, and wound infection in 3% patients. There was no significant effect of age, sex, smoking habit, diabetes, hypertension, and coronary artery disease on 30-day morbidity and mortality. Neoadjuvant therapy (p=0.049), right pneumonectomy (p=0.01), and intraoperative blood transfusion (p=0.049) were associated with significantly increased morbidity. The duration of intensive care unit and hospital stays was significantly longer in patients with respiratory failure and bronchopleural fistula. Conclusion: Pneumonectomy is a high-risk procedure in patients with neoadjuvant therapy, right pneumonectomy, and intraoperative blood transfusion. However, we believe that it is possible to reduce the risk factors with careful preoperative evaluation, rigorous anesthetic assessment and surgical interventions.
Açıklama
Anahtar Kelimeler
Morbidity, Mortality, Pneumonectomy, Cell Lung-Cancer, Randomized Controlled-Trial, Completion Pneumonectomy, Operative Mortality, Complications, Chemotherapy, Radiotherapy, Resection, Surgery, Therapy
Kaynak
Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal Of Thoracic And Cardiovascular Surgery
WoS Q Değeri
Q4
Scopus Q Değeri
Q3
Cilt
22
Sayı
2